145 related articles for article (PubMed ID: 38650694)
1. Histone deacetylase 10, a potential epigenetic target for therapy.
Cheng F; Zheng B; Wang J; Zhao G; Yao Z; Niu Z; He W
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33997894
[TBL] [Abstract][Full Text] [Related]
2. Polyamine Deacetylase Structure and Catalysis: Prokaryotic Acetylpolyamine Amidohydrolase and Eukaryotic HDAC10.
Shinsky SA; Christianson DW
Biochemistry; 2018 Jun; 57(22):3105-3114. PubMed ID: 29533602
[TBL] [Abstract][Full Text] [Related]
3. HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression.
Ling H; Li Y; Peng C; Yang S; Seto E
NAR Cancer; 2024 Jun; 6(2):zcae018. PubMed ID: 38650694
[TBL] [Abstract][Full Text] [Related]
4. HDAC10 blockade upregulates SPARC expression thereby repressing melanoma cell growth and BRAF inhibitor resistance.
Ling H; Li Y; Peng C; Yang S; Seto E
bioRxiv; 2023 Dec; ():. PubMed ID: 38106051
[TBL] [Abstract][Full Text] [Related]
5. Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain.
Tong JJ; Liu J; Bertos NR; Yang XJ
Nucleic Acids Res; 2002 Mar; 30(5):1114-23. PubMed ID: 11861901
[TBL] [Abstract][Full Text] [Related]
6. Silencing of secreted protein acidic and rich in cysteine inhibits the growth of human melanoma cells with G arrest induction.
Horie K; Tsuchihara M; Nakatsura T
Cancer Sci; 2010 Apr; 101(4):913-9. PubMed ID: 20100207
[TBL] [Abstract][Full Text] [Related]
7. HDAC10 promotes angiogenesis in endothelial cells through the PTPN22/ERK axis.
Duan B; Ye D; Zhu S; Jia W; Lu C; Wang G; Guo X; Yu Y; Wu C; Kang J
Oncotarget; 2017 Sep; 8(37):61338-61349. PubMed ID: 28977867
[TBL] [Abstract][Full Text] [Related]
8. Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cells.
Zeyen P; Zeyn Y; Herp D; Mahmoudi F; Yesiloglu TZ; Erdmann F; Schmidt M; Robaa D; Romier C; Ridinger J; Herbst-Gervasoni CJ; Christianson DW; Oehme I; Jung M; Krämer OH; Sippl W
Eur J Med Chem; 2022 Apr; 234():114272. PubMed ID: 35306288
[TBL] [Abstract][Full Text] [Related]
9. HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis.
Emmons MF; Bennett RL; Riva A; Gupta K; Carvalho LADC; Zhang C; Macaulay R; Dupéré-Richér D; Fang B; Seto E; Koomen JM; Li J; Chen YA; Forsyth PA; Licht JD; Smalley KSM
Nat Commun; 2023 Nov; 14(1):7759. PubMed ID: 38030596
[TBL] [Abstract][Full Text] [Related]
10. Cell-type-specific alternative polyadenylation promotes oncogenic gene expression in non-small cell lung cancer progression.
Huang K; Zhang Y; Shi X; Yin Z; Zhao W; Huang L; Wang F; Zhou X
Mol Ther Nucleic Acids; 2023 Sep; 33():816-831. PubMed ID: 37675185
[TBL] [Abstract][Full Text] [Related]
11. Exploring structural requirements of HDAC10 inhibitors through comparative machine learning approaches.
Bhattacharya A; Amin SA; Kumar P; Jha T; Gayen S
J Mol Graph Model; 2023 Sep; 123():108510. PubMed ID: 37216830
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer.
Mustafa AM; Krämer OH
Pharmacol Rev; 2023 Jan; 75(1):35-61. PubMed ID: 36752816
[TBL] [Abstract][Full Text] [Related]
13. Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 Knockout.
Steimbach RR; Herbst-Gervasoni CJ; Lechner S; Stewart TM; Klinke G; Ridinger J; Géraldy MNE; Tihanyi G; Foley JR; Uhrig U; Kuster B; Poschet G; Casero RA; Médard G; Oehme I; Christianson DW; Gunkel N; Miller AK
J Am Chem Soc; 2022 Oct; 144(41):18861-18875. PubMed ID: 36200994
[TBL] [Abstract][Full Text] [Related]
14. SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine model.
Bellenghi M; Talarico G; Botti L; Puglisi R; Tabolacci C; Portararo P; Piva A; Pontecorvi G; Carè A; Colombo MP; Mattia G; Sangaletti S
Oncogene; 2022 Aug; 41(34):4055-4065. PubMed ID: 35851846
[TBL] [Abstract][Full Text] [Related]
15. Acetylation dependent translocation of EWSR1 regulates CHK2 alternative splicing in response to DNA damage.
Zhang T; Wang Z; Liu M; Liu L; Yang X; Zhang Y; Bie J; Li Y; Ren M; Song C; Wang W; Tan H; Luo J
Oncogene; 2022 Jul; 41(29):3694-3704. PubMed ID: 35732801
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
